A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors

Clinical trial NCT06403436 · COMPLETED

Trial details

NCT number: NCT06403436
Sponsor: TOLREMO therapeutics AG
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Adult Solid Tumor Adult Disease Cancer NSCLC EGFR KRAS G12C Squamous Cell Lung Cancer

Start date: 2023-11-07
Primary completion: 2026-06-30
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.